Brian Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Brian Lim has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Evan Lipsitz
Department of Cardiothoracic and Vascular Surgery Albert Einstein College of Medicine New York NY
2 shared publications- Megan Lynn Schultz
Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan
2 shared publications - Robert E. Michler
Departments of Surgery and Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY
2 shared publications - Stephen J. Forest
Division of Critical Care Medicine, Montefiore Medical Center, Bronx, NY
2 shared publications - Brian J. Anderson
Assistant Professor of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 5036 Gates Building, Philadelphia, PA 19104, USA
1 shared publication - Caitlin Forker
Division of Pulmonary, Allergy, and Critical Care
1 shared publication
Latest Publications
- 6 March 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 170, 147-154
Relation of Community-Level Socioeconomic Status to Delayed Diagnosis of Acute Type A Aortic Dissection
- 6 March 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 170, 147-154
Relation of Community-Level Socioeconomic Status to Delayed Diagnosis of Acute Type A Aortic Dissection
- 4 January 2021
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (1)
The ABO histo-blood group, endothelial activation, and acute respiratory distress syndrome risk in critical illness
BACKGROUND. The ABO histo-blood group is defined by carbohydrate modifications and is associated with risk for multiple diseases, including acute respiratory distress syndrome (ARDS). We hypothesized that genetically determined blood subtype A1 is associated with increased risk of ARDS and markers of microvascular dysfunction and coagulation. METHODS. We conducted analyses in 3 cohorts of critically ill trauma and sepsis patients (n = 3710) genotyped on genome-wide platforms to determine the association of the A1 blood type genotype with ARDS risk. We subsequently determined whether associations were present in FUT2-defined nonsecretors who lack ABO antigens on epithelium, but not endothelium. In a patient subgroup, we determined the associations of blood type with plasma levels of endothelial glycoproteins and disseminated intravascular coagulation (DIC). Lastly, we tested whether blood type A was associated with less donor lung injury recovery during human ex vivo lung perfusion (EVLP). RESULTS. The A1 genotype was associated with a higher risk of moderate to severe ARDS relative to type O in all 3 populations. In sepsis, this relationship was strongest in nonpulmonary infections. The association persisted in nonsecretors, suggesting a vascular mechanism. The A1 genotype was also associated with higher DIC risk as well as concentrations of thrombomodulin and von Willebrand factor, which in turn were associated with ARDS risk. Blood type A was also associated with less lung injury recovery during EVLP. CONCLUSION. We identified a replicable association between ABO blood type A1 and risk of ARDS among the critically ill, possibly mediated through microvascular dysfunction and coagulation. FUNDING. NIH HL122075, HL125723, HL137006, HL137915, DK097307, HL115354, HL101779, and the University of Pennsylvania McCabe Fund Fellowship Award.
- 4 January 2021
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 131 (1)
The ABO histo-blood group, endothelial activation, and acute respiratory distress syndrome risk in critical illness
BACKGROUND. The ABO histo-blood group is defined by carbohydrate modifications and is associated with risk for multiple diseases, including acute respiratory distress syndrome (ARDS). We hypothesized that genetically determined blood subtype A1 is associated with increased risk of ARDS and markers of microvascular dysfunction and coagulation. METHODS. We conducted analyses in 3 cohorts of critically ill trauma and sepsis patients (n = 3710) genotyped on genome-wide platforms to determine the association of the A1 blood type genotype with ARDS risk. We subsequently determined whether associations were present in FUT2-defined nonsecretors who lack ABO antigens on epithelium, but not endothelium. In a patient subgroup, we determined the associations of blood type with plasma levels of endothelial glycoproteins and disseminated intravascular coagulation (DIC). Lastly, we tested whether blood type A was associated with less donor lung injury recovery during human ex vivo lung perfusion (EVLP). RESULTS. The A1 genotype was associated with a higher risk of moderate to severe ARDS relative to type O in all 3 populations. In sepsis, this relationship was strongest in nonpulmonary infections. The association persisted in nonsecretors, suggesting a vascular mechanism. The A1 genotype was also associated with higher DIC risk as well as concentrations of thrombomodulin and von Willebrand factor, which in turn were associated with ARDS risk. Blood type A was also associated with less lung injury recovery during EVLP. CONCLUSION. We identified a replicable association between ABO blood type A1 and risk of ARDS among the critically ill, possibly mediated through microvascular dysfunction and coagulation. FUNDING. NIH HL122075, HL125723, HL137006, HL137915, DK097307, HL115354, HL101779, and the University of Pennsylvania McCabe Fund Fellowship Award.
- 30 October 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (11)
Cover Image: Volume 34 Issue 11
- 30 October 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (11)
Cover Image: Volume 34 Issue 11
- Open Access
- 17 August 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (11) , 1374-1376
Aortic recoarctation and pseudoaneurysm five decades after repair
Background: Coarctation of the aorta is a congenital cardiac defect characterized by a narrowing of the proximal thoracic aorta. Despite excellent long‐term results, surgical repair is rarely complicated by recoarctation. Methods/Results: We describe a case with the longest time to reintervention to date, featuring surgical repair of delayed aortic recoarctation and pseudoaneurysm 53 years after the initial operation. Discussion: This case emphasizes the need for lifelong surveillance in this patient population and exemplifies a multidisciplinary approach in evaluating treatment options of complex aortic pathology, including open and endovascular considerations.
- 17 August 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (11) , 1374-1376
Open AccessAortic recoarctation and pseudoaneurysm five decades after repair
Background: Coarctation of the aorta is a congenital cardiac defect characterized by a narrowing of the proximal thoracic aorta. Despite excellent long‐term results, surgical repair is rarely complicated by recoarctation. Methods/Results: We describe a case with the longest time to reintervention to date, featuring surgical repair of delayed aortic recoarctation and pseudoaneurysm 53 years after the initial operation. Discussion: This case emphasizes the need for lifelong surveillance in this patient population and exemplifies a multidisciplinary approach in evaluating treatment options of complex aortic pathology, including open and endovascular considerations.